Skip to main content
SpringerLink
Log in

Endoscopic Management of Biliary Obstruction

  • Chapter
  • First Online:
Cholestatic Liver Disease

Part of the book series: Clinical Gastroenterology ((CG))

Abstract

Endoscopic management of biliary obstruction has evolved tremendously since the introduction of flexible fiber-optic endoscopes over 50 years ago. Endoscopic retrograde cholangiography (ERC) was introduced nearly a decade after flexible upper endoscopy and has since become the mainstay of therapy for relieving obstruction of the biliary tract. In addition, endoscopic ultrasonography (EUS) has gained increasing favor as an auxiliary diagnostic and therapeutic modality for management of obstructive biliary tract disorders. In this chapter, we review the current and continually evolving role of gastrointestinal endoscopy in the management of biliary obstruction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McCune WS. ERCP at thirty years: an interview with Dr. William S. McCune (1909–1998). Gastrointest Endosc. 1998;48:643–4.

    CAS  PubMed  Google Scholar 

  2. Papachristou G, Gleeson F, Papachristou D, et al. Endoscopist administered sedation during ERCP: impact of chronic narcotic/benzodiazepine use and predictive risk of reversal agent utilization. Am J Gastroenterol. 2007;102:738–43.

    CAS  PubMed  Google Scholar 

  3. Tabibian JH, Macura SI, O'Hara SP, et al. Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography. Lab Invest. 2013;93:733–43.

    CAS  PubMed  Google Scholar 

  4. Tabibian JH, Lindor KD. Primary sclerosing cholangitis: a review and update on therapeutic developments. Expert Rev Gastroenterol Hepatol. 2013;7:103–14.

    CAS  PubMed  Google Scholar 

  5. O'Hara SP, Tabibian JH, Splinter PL, et al. The dynamic biliary epithelia: molecules, pathways, and disease. J Hepatol. 2013;58:575–82.

    PubMed  Google Scholar 

  6. Wiesner RH, Grambsch PM, Dickson ER, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology. 1989;10:430–6.

    CAS  PubMed  Google Scholar 

  7. Farrant JM, Hayllar KM, Wilkinson ML, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 1991;100:1710–7.

    CAS  PubMed  Google Scholar 

  8. Tabibian JH, Lindor KD. Challenges of cholangiocarcinoma detection in patients with primary sclerosing cholangitis. J Anal Oncol. 2012;1:50–5.

    Google Scholar 

  9. Kaplan GG, Laupland KB, Butzner D, et al. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol. 2007;102:1042–9.

    PubMed  Google Scholar 

  10. Tabibian JH, Weeding E, Jorgensen RA, et al. Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis – a pilot study. Aliment Pharmacol Ther. 2013;37:604–12.

    CAS  PubMed  Google Scholar 

  11. Alabraba E, Nightingale P, Gunson B, et al. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl. 2009;15:330–40.

    PubMed  Google Scholar 

  12. Graziadei IW. Live donor liver transplantation for primary sclerosing cholangitis: is disease recurrence increased? Curr Opin Gastroenterol. 2011;27:301–5.

    PubMed  Google Scholar 

  13. Landaverde C, Ng V, Sato A, et al. De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis. Ann Hepatol. 2009;8:379–83.

    PubMed  Google Scholar 

  14. Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–78.

    CAS  PubMed  Google Scholar 

  15. Beuers U, Boberg KM, Chapman RW, et al. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237–67.

    Google Scholar 

  16. Gardner TB, Baron TH. Optimizing cholangiography when performing endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2008;6:734–40.

    PubMed  Google Scholar 

  17. Angulo P, Maor-Kendler Y, Lindor KD. Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology. 2002;35:1494–500.

    PubMed  Google Scholar 

  18. Tabibian JH, Masyuk AL, Masyuk TV, LaRusso NF. Cholangiocyte physiology. Compr Physiol. 2013;3:541–65.

    PubMed  Google Scholar 

  19. Papachristou G, Smyrk T, Baron T. Endoscopic retrograde cholangiopancreatography tissue sampling: when and how? Clin Gastroenterol Hepatol. 2007;5:783–90.

    PubMed  Google Scholar 

  20. Varadarajulu S, Eloubeidi M, Wilcox C. Prospective evaluation of indeterminate ERCP findings by intraductal ultrasound. J Gastroenterol Hepatol. 2007;22:2086–92.

    PubMed  Google Scholar 

  21. Shah R, Langer D, Antillon M, et al. Cholangioscopy and cholangioscopic forceps biopsy in patients with indeterminate pancreaticobiliary pathology. Clin Gastroenterol Hepatol. 2006;4:219–25.

    PubMed  Google Scholar 

  22. Victor DW, Sherman S, Karakan T, et al. Current endoscopic approach to indeterminate biliary strictures. World J Gastroenterol. 2012;18:6197–205.

    PubMed Central  PubMed  Google Scholar 

  23. Heif M, Yen RD, Shah RJ. ERCP with probe-based confocal laser endomicroscopy for the evaluation of dominant biliary stenoses in primary sclerosing cholangitis patients. Dig Dis Sci. 2013;58:2068–74.

    CAS  PubMed  Google Scholar 

  24. Draganov PV, Chauhan S, Wagh MS, et al. Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study. Gastrointest Endosc. 2012;75:347–53.

    PubMed  Google Scholar 

  25. Petersen BT. Cholangioscopy for special applications: primary sclerosing cholangitis, liver transplant, and selective duct access. Gastrointest Endosc Clin N Am. 2009;19:579–86.

    PubMed  Google Scholar 

  26. Moon JH, Terheggen G, Choi HJ, et al. Peroral cholangioscopy: diagnostic and therapeutic applications. Gastroenterology. 2013;144:276–82.

    PubMed  Google Scholar 

  27. Osanai M, Itoi T, Igarashi Y, et al. Peroral video cholangioscopy to evaluate indeterminate bile duct lesions and preoperative mucosal cancerous extension: a prospective multicenter study. Endoscopy. 2013;45:635–42.

    CAS  PubMed  Google Scholar 

  28. Nishikawa T, Tsuyuguchi T, Sakai Y, et al. Comparison of the diagnostic accuracy of peroral video-cholangioscopic visual findings and cholangioscopy-guided forceps biopsy findings for indeterminate biliary lesions: a prospective study. Gastrointest Endosc. 2013;77:219–26.

    PubMed  Google Scholar 

  29. Frossard JL, Morel PM. Detection and management of bile duct stones. Gastrointest Endosc. 2010;72:808–16.

    PubMed  Google Scholar 

  30. Williams E, Green J, Beckingham I, et al. British Society of Gastroenterology. Guidelines on the management of common bile duct stones (CBDS). Gut. 2008;57:1004–21.

    CAS  PubMed  Google Scholar 

  31. Carr-Locke D. Therapeutic role of ERCP in the management of suspected common bile duct stones. Gastrointest Endosc. 2002;56:S170–4.

    PubMed  Google Scholar 

  32. Maple JT, Ikenberry SO, Anderson MA, et al. The role of endoscopy in the management of choledocholithiasis. Gastrointest Endosc. 2011;74:731–44.

    PubMed  Google Scholar 

  33. Baron T, Harewood G. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a meta-analysis of randomized, controlled trials. Am J Gastroenterol. 2004;99:1455–60.

    PubMed  Google Scholar 

  34. Weinberg B, Shindy W, Lo S. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones. Cochrane Database Syst Rev. 2006;4, CD004890.

    PubMed  Google Scholar 

  35. Fatima J, Baron T, Topazian M, et al. Pancreaticobiliary and duodenal perforations after periampullary endoscopic procedures: diagnosis and management. Arch Surg. 2007;142:448–54.

    PubMed  Google Scholar 

  36. Disario J, Freeman M, Bjorkman D, et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology. 2004;127:1291–9.

    PubMed  Google Scholar 

  37. Baron T. Endoscopy for bile duct stones. Minerva Gastroenterol Dietol. 2005;51:289–301.

    CAS  PubMed  Google Scholar 

  38. Piraka C, Shah R, Awadallah N, et al. Transpapillary cholangioscopy-directed lithotripsy in patients with difficult bile duct stones. Clin Gastroenterol Hepatol. 2007;5:1333–8.

    PubMed  Google Scholar 

  39. Katsinelos P, Kountouras J, Paroutoglou G, et al. Combination of endoprostheses and oral ursodeoxycholic acid or placebo in the treatment of difficult to extract common bile duct stones. Dig Liver Dis. 2008;40:453–9.

    CAS  PubMed  Google Scholar 

  40. Baron Sr TH, Davee T. Endoscopic management of benign bile duct strictures. Gastrointest Endosc Clin N Am. 2013;23:295–311.

    PubMed  Google Scholar 

  41. Zepeda-Gomez S, Baron TH. Benign biliary strictures: current endoscopic management. Nat Rev Gastroenterol Hepatol. 2011;8:573–81.

    PubMed  Google Scholar 

  42. Dumonceau JM, Tringali A, Blero D, et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012;44:277–98.

    PubMed  Google Scholar 

  43. Tabibian JH, Asham EH, Goldstein L, et al. Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures. Gastrointest Endosc. 2009;69:1236–43.

    PubMed  Google Scholar 

  44. Tabibian JH, Asham EH, Han S, et al. Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video). Gastrointest Endosc. 2010;71:505–12.

    PubMed  Google Scholar 

  45. Baron TH. Covered self-expandable metal stents for benign biliary tract diseases. Curr Opin Gastroenterol. 2011;27:262–7.

    CAS  PubMed  Google Scholar 

  46. Costamagna G, Bulajic M, Tringali A, et al. Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: long-term results. Endoscopy. 2006;38:254–9.

    CAS  PubMed  Google Scholar 

  47. Perri V, Boskoski I, Tringali A, et al. Fully covered self-expandable metal stents in biliary strictures caused by chronic pancreatitis not responding to plastic stenting: a prospective study with 2 years of follow-up. Gastrointest Endosc. 2012;75:1271–7.

    PubMed  Google Scholar 

  48. Adler DG, Baron TH, Davila RE, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2005;62:1–8.

    PubMed  Google Scholar 

  49. Pasha SF, Harrison ME, Das A, et al. Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc. 2007;66:44–51.

    PubMed  Google Scholar 

  50. Graziadei IW, Schwaighofer H, Koch R, et al. Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation. Liver Transpl. 2006;12:718–25.

    PubMed  Google Scholar 

  51. Thethy S, Thomson B, Pleass H, et al. Management of biliary tract complications after orthotopic liver transplantation. Clin Transplant. 2004;18:647–53.

    PubMed  Google Scholar 

  52. Tabibian JH, Yeh HC, Singh VK, et al. Sirolimus may be associated with early recurrence of biliary obstruction in liver transplant patients undergoing endoscopic stenting of biliary strictures. Ann Hepatol. 2011;10:270–6.

    CAS  PubMed  Google Scholar 

  53. Tabibian JH, Girotra M, Yeh HC, et al. Sirolimus based immunosuppression is associated with need for early repeat therapeutic ERCP in liver transplant patients with anastomotic biliary stricture. Ann Hepatol. 2013;12:563–9.

    PubMed  Google Scholar 

  54. Azeem N, Tabibian JH, Baron TH, et al. Use of a single-balloon enteroscope compared with variable-stiffness colonoscopes for endoscopic retrograde cholangiography in liver transplant patients with Roux-en-Y biliary anastomosis. Gastrointest Endosc. 2013;77:568–77.

    PubMed  Google Scholar 

  55. Taylor M, McLeod R, Langer B. Biliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: a meta-analysis. Liver Transpl. 2000;6:302–8.

    CAS  PubMed  Google Scholar 

  56. Ferreira LE, Baron TH. Endoscopic stenting for palliation of malignant biliary obstruction. Expert Rev Med Devices. 2010;7:681–91.

    CAS  PubMed  Google Scholar 

  57. Sewnath M, Karsten T, Prins M, et al. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg. 2002;236:17–27.

    PubMed Central  PubMed  Google Scholar 

  58. van der Gaag NA, Rauws EA, van Eijck CH, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010;362:129–37.

    PubMed  Google Scholar 

  59. Bonin EA, Baron TH. Preoperative biliary stents in pancreatic cancer. J Hepatobiliary Pancreat Sci. 2011;18:621–9.

    PubMed  Google Scholar 

  60. Wasan S, Ross W, Staerkel G, et al. Use of expandable metallic biliary stents in resectable pancreatic cancer. Am J Gastroenterol. 2005;100:2056–61.

    PubMed  Google Scholar 

  61. Singh A, Lee JH. Self-expanding metal stents for preoperative biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer. J Gastrointest Oncol. 2012;3:304–5.

    CAS  PubMed Central  PubMed  Google Scholar 

  62. Weickert U, Venzke T, König J, et al. Why do bilioduodenal plastic stents become occluded? A clinical and pathological investigation on 100 consecutive patients. Endoscopy. 2001;33:786–90.

    CAS  PubMed  Google Scholar 

  63. Moss AC, Morris E, Leyden J, et al. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev. 2007;33:213–21.

    PubMed  Google Scholar 

  64. Pop GH, Richter JA, Sauer B, et al. Bridge to surgery using partially covered self-expandable metal stents (PCMS) in malignant biliary stricture: an acceptable paradigm? Surg Endosc. 2011;25:613–8.

    PubMed  Google Scholar 

  65. Nakai Y, Isayama H, Komatsu Y, et al. Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction. Gastrointest Endosc. 2005;62:742–8.

    PubMed  Google Scholar 

  66. Saleem A, Leggett CL, Murad MH, et al. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc. 2011;74:321–7. e1–3.

    PubMed  Google Scholar 

  67. Almadi MA, Barkun AN, Martel M. No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:27–37. e1.

    PubMed  Google Scholar 

  68. Bakken JC, Baron TH. Metal stents and biliary obstruction secondary to lymphoma: a tale of caution. Dig Dis Sci. 2010;55:3636.

    PubMed  Google Scholar 

  69. Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2013;28:593–607.

    PubMed  Google Scholar 

  70. Kozarek RA. Malignant hilar strictures: one stent or two? Plastic versus self-expanding metal stents? The role of liver atrophy and volume assessment as a predictor of survival in patients undergoing endoscopic stent placement. Gastrointest Endosc. 2010;72:736–8.

    PubMed  Google Scholar 

  71. De Palma G, Galloro G, Siciliano S, et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001;53:547–53.

    PubMed  Google Scholar 

  72. Chang W, Kortan P, Haber G. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc. 1998;47:354–62.

    CAS  PubMed  Google Scholar 

  73. Siddiqui A, Shahid H, Sarkar A, et al. Stage of hilar cholangiocarcinoma predicts recurrence of biliary obstruction in patients with metal stents. Clin Gastroenterol Hepatol. 2013;11:1169–73.

    PubMed  Google Scholar 

  74. Peters R, Williams S, Lombard M, et al. The management of high-grade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses. Endoscopy. 1997;29:10–6.

    CAS  PubMed  Google Scholar 

  75. Cheng J, Bruno M, Bergman J, et al. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest Endosc. 2002;56:33–9.

    PubMed  Google Scholar 

  76. Perdue D, Freeman M, Disario J, et al. The ERCP Outcome Study (ERCOST) group. Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study. J Clin Gastroenterol. 2008;42:1040–6.

    PubMed  Google Scholar 

  77. Costamagna G, Tringali A, Petruzziello L, et al. Hilar tumours. Can J Gastroenterol. 2004;18:451–4.

    PubMed  Google Scholar 

  78. Gerges C, Schumacher B, Terheggen G, et al. Expandable metal stents for malignant hilar biliary obstruction. Gastrointest Endosc Clin N Am. 2011;21:481–97. ix.

    PubMed  Google Scholar 

  79. Mukai T, Yasuda I, Nakashima M, et al. Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial. J Hepatobiliary Pancreat Sci. 2013;20:214–22.

    PubMed  Google Scholar 

  80. Ortner M, Liebetruth J, Schreiber S, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology. 1998;114:536–42.

    CAS  PubMed  Google Scholar 

  81. Wiedmann M, Berr F, Schiefke I, et al. Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. Gastrointest Endosc. 2004;60:68–75.

    PubMed  Google Scholar 

  82. Ortner M. Photodynamic therapy for cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2001;8:137–9.

    CAS  PubMed  Google Scholar 

  83. Kahaleh M, Mishra R, Shami V, et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol. 2008;6:290–7.

    PubMed  Google Scholar 

  84. Baron T. Photodynamic therapy: standard of care for palliation of cholangiocarcinoma? Clin Gastroenterol Hepatol. 2008;6:266–7.

    PubMed  Google Scholar 

  85. Wadsworth CA, Westaby D, Khan SA. Endoscopic radiofrequency ablation for cholangiocarcinoma. Curr Opin Gastroenterol. 2013;29:305–11.

    PubMed  Google Scholar 

  86. Simmons DT, Baron TH, Petersen BT, et al. A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma. Am J Gastroenterol. 2006;101:1792–6.

    PubMed  Google Scholar 

  87. Gluck M, Cantone N, Brandabur J, et al. A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis. J Clin Gastroenterol. 2008;42:1032–9.

    PubMed  Google Scholar 

  88. McLoughlin M, Enns R. Endoscopy in the management of primary sclerosing cholangitis. Curr Gastroenterol Rep. 2008;10:177–85.

    PubMed  Google Scholar 

  89. Charatcharoenwitthaya P, Enders F, Halling K, et al. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology. 2008;48:1106–17.

    CAS  PubMed  Google Scholar 

  90. Tischendorf J, Krüger M, Trautwein C, et al. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy. 2006;38:665–9.

    CAS  PubMed  Google Scholar 

  91. Loeser CS, Robert ME, Mennone A, et al. Confocal endomicroscopic examination of malignant biliary strictures and histologic correlation with lymphatics. J Clin Gastroenterol. 2011;45:246–52.

    PubMed Central  PubMed  Google Scholar 

  92. Chahal P, Baron TH, Poterucha JJ, et al. Endoscopic retrograde cholangiography in post-orthotopic liver transplant population with Roux-en-Y biliary reconstruction. Liver Transpl. 2007;13:1168–73.

    PubMed  Google Scholar 

  93. Saleem A, Baron TH, Gostout CJ, et al. Endoscopic retrograde cholangiopancreatography using a single-balloon enteroscope in patients with altered Roux-en-Y anatomy. Endoscopy. 2010;42:656–60.

    CAS  PubMed  Google Scholar 

  94. Baron TH, Song LM, Ferreira LE, et al. Novel approach to therapeutic ERCP after long-limb Roux-en-Y gastric bypass surgery using transgastric self-expandable metal stents: experimental outcomes and first human case study (with videos). Gastrointest Endosc. 2012;75:1258–63.

    PubMed  Google Scholar 

  95. Saleem A, Levy MJ, Petersen BT, et al. Laparoscopic assisted ERCP in Roux-en-Y gastric bypass (RYGB) surgery patients. J Gastrointest Surg. 2012;16:203–8.

    PubMed  Google Scholar 

  96. Abu Dayyeh BK, Baron TH. Development of a hybrid percutaneous-endoscopic approach for the complete clearance of gallstones. Clin Gastroenterol Hepatol. 2012;10:947–9.

    PubMed  Google Scholar 

  97. Law R, Wong Kee Song LM, Petersen BT, et al. Single-session ERCP in patients with previous Roux-en-Y gastric bypass using percutaneous-assisted transprosthetic endoscopic therapy: a case series. Endoscopy. 2013;45:671–5.

    CAS  PubMed  Google Scholar 

  98. Tse F, Barkun J, Romagnuolo J, et al. Nonoperative imaging techniques in suspected biliary tract obstruction. HPB (Oxford). 2006;8:409–25.

    Google Scholar 

  99. Ohshima Y, Yasuda I, Kawakami H, et al. EUS-FNA for suspected malignant biliary strictures after negative endoscopic transpapillary brush cytology and forceps biopsy. J Gastroenterol. 2011;46:921–8.

    PubMed  Google Scholar 

  100. Levy MJ, Heimbach JK, Gores GJ. Endoscopic ultrasound staging of cholangiocarcinoma. Curr Opin Gastroenterol. 2012;28:244–52.

    PubMed  Google Scholar 

  101. Gleeson F, Levy M. Endoscopic ultrasound (EUS) guided access and therapy of pancreatico-biliary disorders. Minerva Gastroenterol Dietol. 2008;54:151–60.

    CAS  PubMed  Google Scholar 

  102. Khashab MA, Varadarajulu S. Endoscopic ultrasonography as a therapeutic modality. Curr Opin Gastroenterol. 2012;28:467–76.

    PubMed  Google Scholar 

  103. Sarkaria S, Lee HS, Gaidhane M, et al. Advances in endoscopic ultrasound-guided biliary drainage: a comprehensive review. Gut Liver. 2013;7:129–36.

    PubMed Central  PubMed  Google Scholar 

  104. Shami V, Kahaleh M. Endoscopic ultrasonography (EUS)-guided access and therapy of pancreatico-biliary disorders: EUS-guided cholangio and pancreatic drainage. Gastrointest Endosc Clin N Am. 2007;17:581–93.

    PubMed  Google Scholar 

  105. Ang T, Teo E, Fock K. EUS-guided transduodenal biliary drainage in unresectable pancreatic cancer with obstructive jaundice. JOP. 2007;8:438–43.

    PubMed  Google Scholar 

  106. Kahaleh M, Hernandez A, Tokar J, et al. Interventional EUS-guided cholangiography: evaluation of a technique in evolution. Gastrointest Endosc. 2006;64:52–9.

    PubMed  Google Scholar 

  107. Park do H. Endoscopic ultrasonography-guided hepaticogastrostomy. Gastrointest Endosc Clin N Am. 2012;22:271–80. ix.

    PubMed  Google Scholar 

  108. Perez-Miranda M, Barclay RL, Kahaleh M. Endoscopic ultrasonography-guided endoscopic retrograde cholangiopancreatography: endosonographic cholangiopancreatography. Gastrointest Endosc Clin N Am. 2012;22:491–509.

    PubMed  Google Scholar 

  109. Yamao K, Bhatia V, Mizuno N, et al. EUS-guided choledochoduodenostomy for palliative biliary drainage in patients with malignant biliary obstruction: results of long-term follow-up. Endoscopy. 2008;40:340–2.

    CAS  PubMed  Google Scholar 

  110. Kahaleh M, Artifon EL, Perez-Miranda M, et al. Endoscopic ultrasonography guided biliary drainage: summary of consortium meeting, May 7th, 2011, Chicago. World J Gastroenterol. 2013;19:1372–9.

    PubMed Central  PubMed  Google Scholar 

  111. Gupta K, Perez-Miranda M, Kahaleh M, et al. Endoscopic ultrasound-assisted bile duct access and drainage: multicenter, long-term analysis of approach, outcomes, and complications of a technique in evolution. J Clin Gastroenterol. 2013;47(10):857–60.

    Google Scholar 

  112. Khashab MA, Fujii LL, Baron TH, et al. EUS-guided biliary drainage for patients with malignant biliary obstruction with an indwelling duodenal stent (with videos). Gastrointest Endosc. 2012;76:209–13.

    PubMed  Google Scholar 

  113. Jang JW, Lee SS, Song TJ, et al. Endoscopic ultrasound-guided transmural and percutaneous transhepatic gallbladder drainage are comparable for acute cholecystitis. Gastroenterology. 2012;142:805–11.

    PubMed  Google Scholar 

  114. Baron TH, Topazian MD. Endoscopic transduodenal drainage of the gallbladder: implications for endoluminal treatment of gallbladder disease. Gastrointest Endosc. 2007;65:735–7.

    PubMed  Google Scholar 

  115. Noh SH, Park do H, Kim YR, et al. EUS-guided drainage of hepatic abscesses not accessible to percutaneous drainage (with videos). Gastrointest Endosc. 2010;71:1314–9.

    PubMed  Google Scholar 

  116. Shami V, Talreja J, Mahajan A, et al. EUS-guided drainage of bilomas: a new alternative? Gastrointest Endosc. 2008;67:136–40.

    PubMed  Google Scholar 

  117. Anderson MA, Fisher L, Jain R, et al. Complications of ERCP. Gastrointest Endosc. 2012;75:467–73.

    PubMed  Google Scholar 

  118. Early DS, Acosta RD, Chandrasekhara V, et al. Adverse events associated with EUS and EUS with FNA. Gastrointest Endosc. 2013;77:839–43.

    PubMed  Google Scholar 

  119. Balmadrid B, Kozarek R. Prevention and management of adverse events of endoscopic retrograde cholangiopancreatography. Gastrointest Endosc Clin N Am. 2013;23:385–403.

    PubMed  Google Scholar 

  120. Ferreira L, Baron T. Post-sphincterotomy bleeding: who, what, when, and how. Am J Gastroenterol. 2007;102:2850–8.

    PubMed  Google Scholar 

  121. Baron TH, Wong Kee Song LM, Zielinski MD, et al. A comprehensive approach to the management of acute endoscopic perforations (with videos). Gastrointest Endosc. 2012;76:838–59.

    PubMed  Google Scholar 

  122. Kapral C, Duller C, Wewalka F, et al. Case volume and outcome of endoscopic retrograde cholangiopancreatography: results of a nationwide Austrian benchmarking project. Endoscopy. 2008;40:625–30.

    CAS  PubMed  Google Scholar 

  123. Freeman M. Understanding risk factors and avoiding complications with endoscopic retrograde cholangiopancreatography. Curr Gastroenterol Rep. 2003;5:145–53.

    PubMed  Google Scholar 

  124. Elta G. Temporary prophylactic pancreatic stents: which patients need them? Gastrointest Endosc. 2008;67:262–4.

    PubMed  Google Scholar 

  125. Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366:1414–22.

    CAS  PubMed Central  PubMed  Google Scholar 

Download references

Funding Sources

JHT is supported by NIH T32 DK007198.

Author information

Authors and Affiliations

  1. Division of Gastroenterology & Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA

    James H. Tabibian M.D.

  2. Division of Gastroenterology & Hepatology, Advanced Therapeutic Endoscopy, Department of Medicine, University of North Carolina, 41041 Bioinformatics Blvd, CB 7080, Chapel Hill, NC, 27599-0001, USA

    Todd H. Baron M.D.

Authors
  1. James H. Tabibian M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Todd H. Baron M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Todd H. Baron M.D. .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, Arizona, USA

    Elizabeth J. Carey

  2. Mayo Clinic, Phoenix, Arizona, USA

    Keith D. Lindor

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Tabibian, J.H., Baron, T.H. (2014). Endoscopic Management of Biliary Obstruction. In: Carey, E., Lindor, K. (eds) Cholestatic Liver Disease. Clinical Gastroenterology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1013-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1013-7_12

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-1012-0

  • Online ISBN: 978-1-4939-1013-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation